BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Treatment
13 results:

  • 1. Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.
    Lin J; Cao Y; Yu L; Lin L
    Medicine (Baltimore); 2018 Sep; 97(39):e12336. PubMed ID: 30278510
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial.
    Kawanaka M; Watari J; Kamiya N; Yamasaki T; Kondo T; Toyoshima F; Ikehara H; Tomita T; Oshima T; Fukui H; Daimon T; Das KM; Miwa H
    Br J Cancer; 2016 Jan; 114(1):21-9. PubMed ID: 26671747
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Resolution of Benign and Malignant Sebaceous Neoplasms, in a Renal Transplant Patient Treated With Everolimus.
    Donati M; Paolino G; Muscardin L; Panetta C; Donati P
    Exp Clin Transplant; 2017 Feb; 15(1):100-102. PubMed ID: 25924010
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Loss of mlh1 confers resistance to PI3Kβ inhibitors in renal clear cell carcinoma with SETD2 mutation.
    Feng C; Ding G; Jiang H; Ding Q; Wen H
    Tumour Biol; 2015 May; 36(5):3457-64. PubMed ID: 25528216
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer.
    Stewart GD; O'Mahony FC; Laird A; Rashid S; Martin SA; Eory L; Lubbock AL; Nanda J; O'Donnell M; Mackay A; Mullen P; McNeill SA; Riddick AC; Aitchison M; Berney D; Bex A; Overton IM; Harrison DJ; Powles T
    Eur Urol; 2014 Nov; 66(5):956-63. PubMed ID: 24821582
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Determining eligibility for and preparation to kidney transplantation of a patient with Lynch syndrome--a case report and literature review.
    Gozdowska J; Bieniasz M; Wszoła M; Kieszek R; Domagała P; Drozdowski J; Tomaszek A; Kwiatkowski A; Chmura A; Durlik M
    Ann Transplant; 2014 Mar; 19():124-8. PubMed ID: 24614524
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis.
    Abouassaly R; Finelli A; Tomlinson GA; Urbach DR; Alibhai SM
    BJU Int; 2011 Dec; 108(11):1806-12. PubMed ID: 21599823
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Thymosin beta 4 expression and nuclear transport are regulated by hmlh1.
    Brieger A; Plotz G; Zeuzem S; Trojan J
    Biochem Biophys Res Commun; 2007 Dec; 364(4):731-6. PubMed ID: 17967441
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome.
    Levi Z; Hazazi R; Kedar-Barnes I; Hodak E; Gal E; Mor E; Niv Y; Winkler J
    Am J Transplant; 2007 Feb; 7(2):476-9. PubMed ID: 17229076
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNA mismatch repair genes in renal cell carcinoma.
    Deguchi M; Shiina H; Igawa M; Kaneuchi M; Nakajima K; Dahiya R
    J Urol; 2003 Jun; 169(6):2365-71. PubMed ID: 12771799
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration hnpcc family: molecular genetic, diagnostic, and management implications.
    Lynch HT; Taylor RJ; Lynch JF; Knezetic JA; Barrows A; Fodde R; Wijnen J; Wagner A
    Am J Gastroenterol; 2003 Mar; 98(3):664-70. PubMed ID: 12650804
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of DNA mismatch repair proteins hMSH2 and hmlh1 and the cyclin G1 inhibitor, p21(waf1/cip1) in pediatric tumors: correlation with response to therapy.
    Idikio HA
    Oncol Rep; 2001; 8(5):965-71. PubMed ID: 11496300
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II.
    Lynch HT; Lanspa SJ; Boman BM; Smyrk T; Watson P; Lynch JF; Lynch PM; Cristofaro G; Bufo P; Tauro AV
    Gastroenterol Clin North Am; 1988 Dec; 17(4):679-712. PubMed ID: 3068137
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.